אביליפיי 10 מ"ג

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

ARIPIPRAZOLE 10 MG

Disponible desde:

BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED

Código ATC:

N05AX12

formulario farmacéutico:

TABLETS

Vía de administración:

PER OS

Fabricado por:

BRISTOL-MYERS SQUIBB S.R.L, ITALY

Grupo terapéutico:

ARIPIPRAZOLE

indicaciones terapéuticas:

Abilify is indicated for the treatment of schizophrenia. And for the treatment of moderate to severe manic episodes in Bipolar I disorder and for the prevention of a new manic episode in patient who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.

Fecha de autorización:

2010-02-01